2002 IPF News and Announcements

10/31/02 - IPF Patient Frank Cabral Profiled on Providence's WJAR NBC-10 |fast connection| slow connection|

10/02/02 - IPF Patient Carl Schmidt Profiled on Indianapolis Fox-59 |fast connection| slow connection|

9/9/02 - IPF Patient Trey Schwab Profiled on Milwaukee's WTMJ NBC-4 |fast connection| slow connection|

09/18/02 - Actimmune Phase III and Pirfenidone Phase II Data For Treating IPF Presented at European Respiratory Society Meeting

09/16/02 - CPF Names Three Nationally Recognized IPF Experts To Scientific Advisory Board

08/28/02 - InterMune Announces Phase III Data Demonstrating Survival Benefit Of Actimmune in IPF

08/15/02 - CPF Partners with the ALA of Southeast Florida to Establish Support Services for IPF Patients

06/11/02 - CPF Partners with the David Geffen School of Medicine at UCLA, Mary D. Harris Memorial Foundation and Pulmonary Fibrosis Association to Host IPF Patient Symposium in Los Angeles

05/08/02 - CPF Partners With Mount Sinai and Yale University To Host IPF Patient Symposium In New York

05/01/02 - Marvin Schwarz, MD television interview with KWGN Fox TV2 Denver (Slow Internet Connections (56k), Fast Internet Connections (256k))

04/30/02 - Educational seminar hosted by Coalition for Pulmonary Fibrosis draws over 130 patients, caregivers and healthcare professionals

04/16/02 - CPF Partners with University of Pennsylvania Medical Center and Good Samaritan Hospital to Provide Support Services to IPF Patients

03/27/02 - Actelion To Investigate Tracleer for the Treatment of IPF

01/18/02 - A Year-End Update From CPF Chairman Marvin I. Schwarz, M.D.

01/16/02 - InterMune Announces Phase III IPF Study Status

01/07/02 - InterMune Receives Fast Track Designation From FDA for Actimmune In the Treatment of Idiopathic Pulmonary Fibrosis. - Phase III IPF Study Maintains Strong Patient Retention -

01/03/02 - A New California Resource: The Interstitial Lung Disease Consultation Clinic at San Francisco General Hospital.